Article Text

Download PDFPDF
CASE REPORT
Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis

Abstract

Direct oral anticoagulants (DOACs)—dabigatran, rivaroxaban, apixaban and edoxaban—are changing the landscape of clinical practice for patients requiring short and long-term anticoagulation. We report a patient with no history of kidney disease developing acute interstitial nephritis (AIN) after starting a DOAC, apixaban. To date, this is the first biopsy proven case of apixaban-induced AIN.

  • acute renal failure
  • haematology (drugs and medicines)
  • renal system
  • haematology (incl blood transfusion)

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.